Barinthus Biotherapeutics
Biotechnology-Research
Website
Company Tagline
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.
Industry Category
Business Keywords
Company Description
Barinthus Biotherapeutics is a leading clinical-stage biopharmaceutical company focused on developing innovative T-cell immunotherapeutic candidates. These novel therapies are designed to harness the power of the immune system to combat chronic infectious diseases, autoimmunity, and cancer. Barinthus Biotherapeutics operates with the guiding principle of helping individuals living with serious illnesses and their families, driving their commitment to pioneering medical advancements.
With a diverse portfolio built around four proprietary platform technologies—ChAdOx, MVA, SNAP-TI, and SNAP-CI—Barinthus Biotherapeutics is actively advancing five product candidates across a range of therapeutic areas. These include VTP-300 for chronic HBV infection, VTP-1000 for celiac disease, and VTP-850 for recurrent prostate cancer. Barinthus Biotherapeutics is headquartered at Units 6-10 Zeus Building, Rutherford Avenue, Harwell, Oxfordshire OX11 0DF, GB, with an additional location at 20400 Century Blvd, Suite 210, Germantown, Maryland 20874, US.
Barinthus Biotherapeutics' dedication to scientific excellence and a robust pipeline development uniquely positions the company to deliver transformative treatments for infectious diseases, autoimmune disorders, and cancers that significantly impact daily life. We invite the management team at Barinthus Biotherapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
Barinthus Biotherapeutics est une société biopharmaceutique de premier plan au stade clinique, axée sur le développement de candidats immunothérapeutiques novateurs ciblant les cellules T. Ces nouvelles thérapies sont conçues pour exploiter la puissance du système immunitaire afin de lutter contre les maladies infectieuses chroniques, l'auto-immunité et le cancer. Barinthus Biotherapeutics opère avec le principe directeur d'aider les personnes atteintes de maladies graves et leurs familles, ce qui motive leur engagement envers les progrès médicaux novateurs.
Avec un portefeuille diversifié construit autour de quatre technologies de plateforme exclusives — ChAdOx, MVA, SNAP-TI et SNAP-CI — Barinthus Biotherapeutics fait progresser activement cinq produits candidats dans divers domaines thérapeutiques. Ceux-ci comprennent VTP-300 pour l'infection chronique par le VHB, VTP-1000 pour la maladie cœliaque et VTP-850 pour le cancer de la prostate récurrent. Le siège social de Barinthus Biotherapeutics est situé à Units 6-10 Zeus Building, Rutherford Avenue, Harwell, Oxfordshire OX11 0DF, GB, avec un emplacement supplémentaire au 20400 Century Blvd, Suite 210, Germantown, Maryland 20874, US.
L'engagement de Barinthus Biotherapeutics envers l'excellence scientifique et le développement d'un pipeline robuste positionne de manière unique l'entreprise pour fournir des traitements transformateurs pour les maladies infectieuses, les troubles auto-immuns et les cancers qui ont un impact significatif sur la vie quotidienne. Nous invitons l'équipe de direction de Barinthus Biotherapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en évidence leur travail révolutionnaire.
Key Personnel / Employees
Compare Companies Side by Side
Compare Barinthus Biotherapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Barinthus BiotherapeuticsMain Company |
Bioinformatics Insti...View Profile |
pHion TherapeuticsView Profile |
Im
ImmPACT BioView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2001 | 2017 | 2017 |
|
Company Size
|
— | 51-200 | 11-50 | 51-200 |
|
City
|
Harwell, Oxfordshire | Belfast, Northern Ireland | West Hills, California | |
|
Country
|
United Kingdom | United Kingdom | ||
|
Skills & Keywords
Comparing with main company
|
19 Total Skills
Biopharmaceutical
Immunotherapy
T-cell Therapy
Chronic Diseases
Autoimmunity
Cancer Research
Drug Development
Celiac
Research
HBV
SNAP
Prostate cancer
Oncology
Non-small cell lung cancer
nanoparticles
HPV
Infectious Disease
Viral vectors
Hepatitis B
|
10 Total
10 Unique
Unique Skills:
Allostery
Bioinformatics
Biomedical Sciences
Computational Biology
Drug Design
Gene Discovery
+4
|
10 Total
10 Unique
Unique Skills:
Antimicrobial
Chemotherapy
Drug Delivery
Formulation
mRNA
Nucleic Acid Therapeutics
+4
|
8 Total
8 Unique
Unique Skills:
autoimmune
Biotechnology
Cancer Therapy
CAR-T
Logic gate
lupus
+2
|
4
Total Companies2001
Oldest Founded1
Countries47
Unique SkillsSimilar Companies
Other organizations in the same industry
QuberTech
Biotechnology-ResearchQuberTech is transforming the natural rubber industry with innovative sustainable biotech solutions...
Entact Bio
Biotechnology-ResearchCreating new medicines by enhancing protein function
Terramer,Inc.
Biotechnology-ResearchA leading bioplastic technologies company specializing and advancing the compostable and packaging s...
4SR Biosciences
Biotechnology-Research4SR is a University of Chicago startup focusing on tRNA diagnostics and therapeutics
Alternative Company Names
This company is also known as